Evidence map›Paper›PMID 37111567›Full record

ArticlePharmaceutics2023

Novel Oxygen- and Curcumin-Laden Ionic Liquid@Silica Nanocapsules for Enhanced Antimicrobial Photodynamic Therapy.

Joana Henriques, João Pina, Mara E M Braga, Ana M A Dias, Patrícia Coimbra, Hermínio C de Sousa

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 9 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Joana HenriquesChemical Process Engineering and Forest Products Research Centre, Department of Chemical Engineering, University of Coimbra, 3030-790 Coimbra, Portugal.ORCID 0000-0001-8016-4846
João PinaCoimbra Chemistry Centre-Institute of Molecular Sciences, Department of Chemistry, University of Coimbra, 3004-535 Coimbra, Portugal.ORCID 0000-0003-1848-1167
Mara E M BragaChemical Process Engineering and Forest Products Research Centre, Department of Chemical Engineering, University of Coimbra, 3030-790 Coimbra, Portugal.ORCID 0000-0003-4142-4021
Ana M A DiasChemical Process Engineering and Forest Products Research Centre, Department of Chemical Engineering, University of Coimbra, 3030-790 Coimbra, Portugal.
Patrícia CoimbraChemical Process Engineering and Forest Products Research Centre, Department of Chemical Engineering, University of Coimbra, 3030-790 Coimbra, Portugal.ORCID 0000-0003-2209-0863
Hermínio C de SousaChemical Process Engineering and Forest Products Research Centre, Department of Chemical Engineering, University of Coimbra, 3030-790 Coimbra, Portugal.ORCID 0000-0002-2629-7805
University of Coimbra · PT

Funding

European Commission EC's 7th Framework Programme,no. 284464Fundação para a Ciência e Tecnologia UIDB/00102/2020Fundação para a Ciência e Tecnologia UIDB/00313/2020Fundação para a Ciência e Tecnologia UIDP/QUI/00102/2020Fundação para a Ciência e Tecnologia UIDP/QUI/00313/2020Luso American Development Foundation A1/Proj. 75/13
6 · The paper itself

Abstract

The efficiency of photodynamic therapy is often limited by the scarcity of oxygen at the target site. To address this problem, this work proposes the development of a new nanosystem for antimicrobial photodynamic therapy applications (aPDT) where the natural-origin photosensitizer curcumin (CUR) is immersed in an oxygen-rich environment. Inspired by the perfluorocarbon-based photosensitizer/O

Indexed as

curcuminionic liquidsoxygen storage/releasephotodynamic inactivationsilica nanocapsules

Identifiers

PMID37111567
PMCPMC10140864
OpenAlexW4361212528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.